Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 39726 - 39750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Etoposide	Approved Investigational	BTG2	7832	upregulated	Etoposide results in increased expression of BTG2 mRNA	1q32.1	A21499
Etoposide	Approved Investigational	BTG3	10950	downregulated	Etoposide results in decreased expression of BTG3 mRNA	21q21.1	A21499
Etoposide	Approved Investigational	BUB1	699	downregulated	Etoposide results in decreased expression of BUB1 mRNA	2q13	A22582
Etoposide	Approved Investigational	BUB1B	701	downregulated	Etoposide results in decreased expression of BUB1B mRNA	15q15.1	A22582
Etoposide	Approved Investigational	CAB39	51719	downregulated	Etoposide results in decreased expression of CAB39 mRNA	2q37.1	A20666
Etoposide	Approved Investigational	CARD10	29775	upregulated	Etoposide results in increased expression of CARD10 mRNA	22q13.1	A21152
Etoposide	Approved Investigational	CASP2	835	upregulated	Etoposide results in increased expression of CASP2 mRNA alternative form	7q34	A20664
Etoposide	Approved Investigational	CCDC51	79714	downregulated	Etoposide results in decreased expression of CCDC51 mRNA	3p21.31	A21499
Etoposide	Approved Investigational	CCNA2	890	downregulated	Etoposide results in decreased expression of CCNA2 mRNA	4q27	A22582
Etoposide	Approved Investigational	CCNB1	891	downregulated	Etoposide results in decreased expression of CCNB1 mRNA	5q13.2	A22582
Etoposide	Approved Investigational	CCND1	595	upregulated	Etoposide results in increased expression of CCND1 mRNA	11q13.3	A22582
Etoposide	Approved Investigational	CCNG2	901	upregulated	Etoposide results in increased expression of CCNG2 mRNA	4q21.1	A21907
Etoposide	Approved Investigational	CCS	9973	upregulated	Etoposide results in increased expression of CCS mRNA	11q13.2	A21863
Etoposide	Approved Investigational	CDC25A	993	downregulated	Etoposide results in decreased expression of CDC25A mRNA	3p21.31	A21499
Etoposide	Approved Investigational	CDC25C	995	downregulated	Etoposide results in decreased expression of CDC25C mRNA	5q31.2	A22582
Etoposide	Approved Investigational	CDC6	990	downregulated	Etoposide results in decreased expression of CDC6 mRNA	17q21.2	A22582
Etoposide	Approved Investigational	CDKN1A	1026	upregulated	Etoposide results in increased expression of CDKN1A mRNA	6p21.2	A22582 A21863 A22266 A22585 A21499 A22586 A22587
Etoposide	Approved Investigational	CDKN3	1033	downregulated	Etoposide results in decreased expression of CDKN3 mRNA	14q22.2	A22582
Etoposide	Approved Investigational	CEACAM1	634	upregulated	Etoposide results in increased expression of CEACAM1 mRNA	19q13.2	A20666
Etoposide	Approved Investigational	CEBPA	1050	downregulated	Etoposide results in decreased expression of CEBPA mRNA	19q13.11	A22588
Etoposide	Approved Investigational	CEBPZ	10153	downregulated	Etoposide results in decreased expression of CEBPZ mRNA	2p22.2	A20666
Etoposide	Approved Investigational	CEL	1056	upregulated	Etoposide results in increased expression of CEL mRNA	9q34.13	A21863
Etoposide	Approved Investigational	CENPF	1063	downregulated	Etoposide results in decreased expression of CENPF mRNA	1q41	A22582
Etoposide	Approved Investigational	CETP	1071	upregulated	Etoposide results in increased expression of CETP mRNA	16q13	A22586
Etoposide	Approved Investigational	CHAF1A	10036	downregulated	Etoposide results in decreased expression of CHAF1A mRNA	19p13.3	A21499

Displaying entries 39726 - 39750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability